Michelle Welds

executive assistant to cto, chief marketing officer and chief operations officer at 4D Molecular Therapeutics LLC - Oakland, CA, US

Michelle Welds's Colleagues at 4D Molecular Therapeutics LLC
Jenny PMP

VP, Program Management

Contact Jenny PMP

Matthew Park

Vice President Information Technology

Contact Matthew Park

Katy Barglow

Vice President Technical Operations

Contact Katy Barglow

Robert Kim

Senior Vice President, Clinical Research and Development

Contact Robert Kim

Leisa Johnson

Vice President, Preclinical Research and Development

Contact Leisa Johnson

Anthony Baldor

Vice President, Corporate Strategy and Development

Contact Anthony Baldor

View All Michelle Welds's Colleagues
Michelle Welds's Contact Details
HQ
510-505-2680
Location
Company
4D Molecular Therapeutics LLC
Michelle Welds's Company Details
4D Molecular Therapeutics LLC logo, 4D Molecular Therapeutics LLC contact details

4D Molecular Therapeutics LLC

Oakland, CA, US • 100 - 249 Employees
BioTech/Drugs

We are 4DMT! Our mission is to boldly innovate to unlock the full potential of gene therapy for countless patients. 4DMT is a leader in next-generation AAV gene therapy discovery through its proprietary therapeutic vector evolution platform that empowers us to invent optimized and proprietary AAV vectors, each specifically tailored for the treatment of a rare disease with a high unmet medical need. We strive to become the most impactful company in the gene therapy industry.We are pioneering the development of precision gene therapies based on our proprietary AAV vectors. Our transformative discovery platform, Therapeutic Vector Evolution, enables our "disease first" approach to product discovery, design and development. We use our platform to discover custom and proprietary AAVs designed for specific tissues and diseases, which we believe will allow us to overcome known limitations of conventional AAV vectors and potentially address a broad range of both rare and large market diseases. Based on our Target Vector Profile for a disease, we select customized capsids in non-human primates from an estimated over one billion vector capsid sequences in our 37 proprietary and diverse AAV vector libraries as of August 1, 2019. We are developing a diverse pipeline in a broad range of therapeutic areas of wholly owned and partnered programs.We seek the best in the industry who identify with our mission and innovative results-driven approach. Our 4 Guiding Principles drive our actions, and they are: Dare to Cure (create big dreams for patients, innovate and take calculated risks to achieve them); Break Boundaries (questioning and moving beyond the status quo); Beyond Yourself (we are patient and team focused); and Prepare & Executive Relentlessly (be proactive and start with the end in mind).

Gene Therapy Adeno-Associated Virus B2B Biotech SaaS Commercial Physical Research Biotechnology Biotech Pharmaceuticals
Details about 4D Molecular Therapeutics LLC
Frequently Asked Questions about Michelle Welds
Michelle Welds currently works for 4D Molecular Therapeutics.
Michelle Welds's role at 4D Molecular Therapeutics is executive assistant to cto, chief marketing officer and chief operations officer.
Michelle Welds's email address is ***@4dmoleculartherapeutics.com. To view Michelle Welds's full email address, please signup to ConnectPlex.
Michelle Welds works in the Biotechnology industry.
Michelle Welds's colleagues at 4D Molecular Therapeutics LLC are Jenny PMP, Matthew Park, Kim Maplestone, Katy Barglow, Robert Kim, Leisa Johnson, Anthony Baldor and others.
Michelle Welds's phone number is ["+16508672123","+16503069331","+16506904012","+14153683552","+16503683552","+16503675070"]
See more information about Michelle Welds